1-53909897-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000792.7(DIO1):c.682-34C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.516 in 1,607,938 control chromosomes in the GnomAD database, including 220,048 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).
Frequency
Genomes: 𝑓 0.45 ( 16505 hom., cov: 32)
Exomes 𝑓: 0.52 ( 203543 hom. )
Consequence
DIO1
NM_000792.7 intron
NM_000792.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0130
Genes affected
DIO1 (HGNC:2883): (iodothyronine deiodinase 1) The protein encoded by this gene belongs to the iodothyronine deiodinase family. It catalyzes the activation, as well as the inactivation of thyroid hormone by outer and inner ring deiodination, respectively. The activation reaction involves the conversion of the prohormone thyroxine (3,5,3',5'-tetraiodothyronine, T4), secreted by the thyroid gland, to the bioactive thyroid hormone (3,5,3'-triiodothyronine, T3) by 5'-deiodination. This protein provides most of the circulating T3, which is essential for growth, differentiation and basal metabolism in vertebrates. This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec) at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jun 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.606 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIO1 | NM_000792.7 | c.682-34C>A | intron_variant | ENST00000361921.8 | NP_000783.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIO1 | ENST00000361921.8 | c.682-34C>A | intron_variant | 1 | NM_000792.7 | ENSP00000354643 | P1 |
Frequencies
GnomAD3 genomes AF: 0.446 AC: 67674AN: 151844Hom.: 16490 Cov.: 32
GnomAD3 genomes
AF:
AC:
67674
AN:
151844
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.531 AC: 132485AN: 249382Hom.: 37035 AF XY: 0.533 AC XY: 71933AN XY: 134954
GnomAD3 exomes
AF:
AC:
132485
AN:
249382
Hom.:
AF XY:
AC XY:
71933
AN XY:
134954
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.523 AC: 761769AN: 1455976Hom.: 203543 Cov.: 29 AF XY: 0.526 AC XY: 381038AN XY: 724736
GnomAD4 exome
AF:
AC:
761769
AN:
1455976
Hom.:
Cov.:
29
AF XY:
AC XY:
381038
AN XY:
724736
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.446 AC: 67713AN: 151962Hom.: 16505 Cov.: 32 AF XY: 0.452 AC XY: 33550AN XY: 74256
GnomAD4 genome
AF:
AC:
67713
AN:
151962
Hom.:
Cov.:
32
AF XY:
AC XY:
33550
AN XY:
74256
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1860
AN:
3478
ClinVar
Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Levothyroxine response Other:1
drug response, no assertion criteria provided | research | Pharmacogenomics/Precision medicine lab, University of Petra | - | - the CC allele had the highest mean free T3 levels after levothyroxine replacement with decreasing concentrations for the CT then the TT genotypes. The CC was predictive of T3 dosage requirements |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at